iBio (IBIO) Interest Expenses (2010 - 2026)
iBio (IBIO) recorded Interest Expenses of -$46,000 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $44,000 a year earlier.
Powered by 
Analysis
iBio (IBIO) Interest Expenses (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio reported Interest Expenses of $53,000, down 75.0% from FY2025.
- Annual Interest Expenses has a five-year compound annual growth rate of -53.6% (FY2021 to FY2026).
- Across earlier fiscal years, Interest Expenses came in at $212,000 in FY2025 (+23.3%), $172,000 in FY2024 (+107.2%), $83,000 in FY2023 (-94.1%) and $1.41 million in FY2022 (-42.5%).
- The fiscal Q4 2026 figure is the lowest quarterly Interest Expenses in data going back to fiscal Q1 2011.
- On a year-over-year basis, Interest Expenses rose in three of the last seven quarters, with growth averaging 5.7%.
- Peak year-over-year performance for Interest Expenses in the last five years was growth of 252.9% in fiscal Q4 2024, against a decline of 92.4% in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $22,000 (Q3 2026), $41,000 (Q2 2026) and $36,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | iBio | 122.79 Mn | 122.79 Mn | - | -46,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Jun 30, 2022 | 225,000.00 |
| Sep 30, 2021 | 609,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Mar 31, 2021 | 612,000.00 |
| Dec 31, 2020 | 615,000.00 |
API Access
iBio Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();